@article{Fleshner_Bhindi_2014, title={Metabolic syndrome and diabetes for the urologist}, volume={8}, url={https://cuaj.ca/index.php/journal/article/view/2314}, DOI={10.5489/cuaj.2314}, abstractNote={<p class="body1">Type 2 diabetes has a number of know urological consequences. Epidemiologic and clinical data suggest a link between metabolic syndrome and prostatic diseases such as benign prostatic hyperplasia (BPH) and prostate cancer. Recent studies have identified metformin as a viable treatment for patients with type 2 diabetes and prostate cancer.</p>}, number={7-8}, journal={Canadian Urological Association Journal}, author={Fleshner, Neil E. and Bhindi, Bimal}, year={2014}, month={Aug.}, pages={S159–61} }